Chimeric antigen receptor T-cell therapy in acute myeloid leukemia

Treatment outcome of relapsed or refractory AML patients remains dismal and new treatment options are needed. Adoptive cell therapy using CAR-T cells is a potentially interesting approach in this. RECENT FINDINGS: Several potentially interesting AML targets are being investigated with CAR-T therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Koedam, Jan, Wermke, Martin, Ehninger, Armin, Cartellieri, Marc, Ehninger, Gerhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
MYELOID DISEASE: Edited by Stephanie Halene
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8815830/
https://www.ncbi.nlm.nih.gov/pubmed/35013048
http://dx.doi.org/10.1097/MOH.0000000000000703

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8815830/
https://www.ncbi.nlm.nih.gov/pubmed/35013048
http://dx.doi.org/10.1097/MOH.0000000000000703

Ejemplares similares